Compare RNAC & AXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RNAC | AXIN |
|---|---|---|
| Founded | 2007 | 2025 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 238.9M | 282.2M |
| IPO Year | 2016 | N/A |
| Metric | RNAC | AXIN |
|---|---|---|
| Price | $7.98 | $10.28 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $34.00 | N/A |
| AVG Volume (30 Days) | ★ 155.3K | 79.6K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,797,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.60 | $9.93 |
| 52 Week High | $13.96 | $10.45 |
| Indicator | RNAC | AXIN |
|---|---|---|
| Relative Strength Index (RSI) | 41.23 | 37.74 |
| Support Level | $5.89 | $10.24 |
| Resistance Level | $8.39 | $10.37 |
| Average True Range (ATR) | 0.56 | 0.03 |
| MACD | -0.21 | -0.01 |
| Stochastic Oscillator | 13.51 | 32.00 |
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
Axiom Intelligence Acquisition Corp 1 is a blank check company.